Risk factors for ulcerative colitis-associated colorectal cancer-Reference-Cited by-同舟云学术

Risk factors for ulcerative colitis-associated colorectal cancer

Published:2020-08-07 Issue:32 Volume:99 Page:e21686
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

de Campos Silva Elen Farinelli,Baima Julio Pinheiro,de Barros Jaqueline Ribeiro,Tanni Suzana Erico,Schreck Thomas,Saad-Hossne Rogerio,Sassaki Ligia Yukie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference39 articles.

1. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts;Peyrin-Biroulet;Inflamm Bowel Dis,2010

2. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease;Munkholm;Aliment Pharmacol Ther,2003

3. Ulcerative colitis and colorectal cancer. A population-based study;Ekbom;N Engl J Med,1990

4. The risk of colorectal cancer in ulcerative colitis: a meta-analysis;Eaden;Gut,2001

5. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease;Söderlund;Gastroenterology,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-22 regulates MASTL expression in intestinal epithelial cells;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-08-01

2. How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer;Biomolecules;2024-05-29

3. Disease clearance in ulcerative colitis: A new therapeutic target for the future;World Journal of Gastroenterology;2024-04-07

4. Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis;Crohn's & Colitis 360;2024-01-01

5. Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn’s Disease and Ulcerative Colitis;Gastroenterology Research;2023-12